Paul R Michl

Array ( [id] => 560603 [patent_doc_number] => 07157555 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-02 [patent_title] => 'Exendin agonist compounds' [patent_app_type] => utility [patent_app_number] => 10/181102 [patent_app_country] => US [patent_app_date] => 1998-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 12384 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157555.pdf [firstpage_image] =>[orig_patent_app_number] => 10181102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4303861 [patent_doc_number] => 06251866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Conjugates targeted to the interleukin-2 receptor' [patent_app_type] => 1 [patent_app_number] => 9/128572 [patent_app_country] => US [patent_app_date] => 1998-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11914 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251866.pdf [firstpage_image] =>[orig_patent_app_number] => 128572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4271583 [patent_doc_number] => 06307016 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Parevins and tachytegrins' [patent_app_type] => 1 [patent_app_number] => 9/128344 [patent_app_country] => US [patent_app_date] => 1998-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 25657 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 591 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/307/06307016.pdf [firstpage_image] =>[orig_patent_app_number] => 128344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1312724 [patent_doc_number] => 06613878 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'PCNA binding substance' [patent_app_type] => B1 [patent_app_number] => 08/945645 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6847 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613878.pdf [firstpage_image] =>[orig_patent_app_number] => 08945645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548624 [patent_doc_number] => 06346261 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Pesticidal composition' [patent_app_type] => B1 [patent_app_number] => 09/119784 [patent_app_country] => US [patent_app_date] => 1998-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1432 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346261.pdf [firstpage_image] =>[orig_patent_app_number] => 09119784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5950783 [patent_doc_number] => 20020006406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'METHOD FOR THE TREATMENT OF STAPHYLOCOCCAL DISEASE' [patent_app_type] => new [patent_app_number] => 09/120030 [patent_app_country] => US [patent_app_date] => 1998-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6450 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006406.pdf [firstpage_image] =>[orig_patent_app_number] => 09120030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031120 [patent_doc_number] => 05994297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Therapy for Staphylococcus aureus' [patent_app_type] => 1 [patent_app_number] => 9/116025 [patent_app_country] => US [patent_app_date] => 1998-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 837 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994297.pdf [firstpage_image] =>[orig_patent_app_number] => 116025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367838 [patent_doc_number] => 06274556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Inhibitors of MadCAM-1-mediated interactions and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 9/109879 [patent_app_country] => US [patent_app_date] => 1998-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 28104 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274556.pdf [firstpage_image] =>[orig_patent_app_number] => 109879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278363 [patent_doc_number] => 20020107174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'COMPOSITION COMPRISING ENDOTOXIN NEUTRALIZING PROTEIN AND DERIVATIVES AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/109175 [patent_app_country] => US [patent_app_date] => 1998-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12621 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107174.pdf [firstpage_image] =>[orig_patent_app_number] => 09109175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4329554 [patent_doc_number] => 06319958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Method of sensitizing microbial cells to antimicrobial compound' [patent_app_type] => 1 [patent_app_number] => 9/102466 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4610 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319958.pdf [firstpage_image] =>[orig_patent_app_number] => 102466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3955709 [patent_doc_number] => 05935932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Bradykinin antagonists containing pentafluorophenylalanine' [patent_app_type] => 1 [patent_app_number] => 9/096716 [patent_app_country] => US [patent_app_date] => 1998-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4344 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935932.pdf [firstpage_image] =>[orig_patent_app_number] => 096716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4321415 [patent_doc_number] => 06331440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Peptide binding the KLVFF-sequence of amyloid-.beta.' [patent_app_type] => 1 [patent_app_number] => 9/095106 [patent_app_country] => US [patent_app_date] => 1998-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6377 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331440.pdf [firstpage_image] =>[orig_patent_app_number] => 095106 [rel_patent_id] =>[rel_patent_doc_number] =>)